tiprankstipranks
Advertisement
Advertisement
Ensysce Biosciences Announces Board Member Curtis Rosebraugh Resignation
PremiumCompany AnnouncementsEnsysce Biosciences Announces Board Member Curtis Rosebraugh Resignation
2M ago
ENSC Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ENSC Earnings this Week: How Will it Perform?
2M ago
Ensysce Biosciences Corrects Series B Preferred Stock Designation
Premium
Company Announcements
Ensysce Biosciences Corrects Series B Preferred Stock Designation
2M ago
Ensysce Biosciences expands global opioid patent portfolio
PremiumThe FlyEnsysce Biosciences expands global opioid patent portfolio
4M ago
Ensysce Biosciences Shareholders Approve Key Corporate Actions
Premium
Company Announcements
Ensysce Biosciences Shareholders Approve Key Corporate Actions
5M ago
Ensysce Biosciences receives EU patent for ADHD therapy
Premium
The Fly
Ensysce Biosciences receives EU patent for ADHD therapy
5M ago
Ensysce Biosciences issued notice of allowance for MPAR tech patent
PremiumThe FlyEnsysce Biosciences issued notice of allowance for MPAR tech patent
6M ago
Ensysce Biosciences receives FDA feedback on PF614 manufacturing
Premium
The Fly
Ensysce Biosciences receives FDA feedback on PF614 manufacturing
6M ago
Ensysce Biosciences Secures $4M Financing for PF614
Premium
Company Announcements
Ensysce Biosciences Secures $4M Financing for PF614
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100